EAACI Congress 2023
BackDupilumab Treatment Induces Clinical Remission in Patients with Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma
Friday 09 Jun, 16:45 PM -
16:57 PM CEST
Hall Y 05+06
ORAL Session